Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea · Delayed Price · Currency is KRW 6,020.00
-60.00 (-0.99%)
Jul 21, 2026, 2:25 PM KST
Hyundai Bioscience Market Cap
Hyundai Bioscience has a market cap or net worth of 586.74 billion as of July 20, 2026. Its market cap has decreased by -15.85% in one year.
Market Cap
586.74B
Enterprise Value
564.03B
Revenue
3.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,020.00
ChartMarket Cap Chart
Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 586.74B, an increase of 1,135.40%. That is a compound annual growth rate of 11.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 586.74B | 23.05% |
| Dec 30, 2025 | 476.83B | -15.13% |
| Dec 30, 2024 | 561.85B | -45.92% |
| Dec 28, 2023 | 1.04T | -4.44% |
| Dec 29, 2022 | 1.09T | 11.39% |
| Dec 30, 2021 | 976.10B | -6.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.62T |
| Celltrion | 40.32T |
| ALTEOGEN | 14.81T |
| Samsung Epis Holdings | 9.85T |
| InBody Co.,Ltd | 723.11B |
| Daewoong | 707.90B |
| Boryung | 701.19B |
| Pharmicell | 665.30B |